You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tremelimumab

Showing 26 - 50 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic or Locally Advanced NSCLC Trial in Ramat Gan (Durvalumab, Tremelimumab, Low dose irradiation)

Recruiting
  • Metastatic or Locally Advanced NSCLC
  • Ramat Gan, Israel
    Sheba Medical Centre
Jan 9, 2022

Squamous NSCLC, Non-Squamous NSCLC Trial (Durvalumab, Tremelimumab)

Withdrawn
  • Squamous Non-small Cell Lung Cancer
  • Non-Squamous Non-small Cell Lung Cancer
  • (no location specified)
Dec 17, 2021

Germ Cell Tumor, Nonseminomatous Germ Cell Tumor, Seminoma Trial in United States (Durvalumab, Tremelimumab)

Active, not recruiting
  • Germ Cell Tumor
  • +5 more
  • Basking Ridge, New Jersey
  • +6 more
May 2, 2022

Invasive Bladder Cancer Trial in Spain (Durvalumab, Tremelimumab, Radiotherapy)

Active, not recruiting
  • Invasive Bladder Cancer
  • Badalona, Barcelona, Spain
  • +6 more
Mar 9, 2022

Infiltrating Bladder Urothelial Carcinoma Trial in France (Durvalumab, Tremelimumab, MVAC Protocol)

Recruiting
  • Infiltrating Bladder Urothelial Carcinoma
  • Paris, Ile De France, France
  • +14 more
Apr 21, 2022

Urothelial Carcinoma Trial in United States (Tremelimumab)

Active, not recruiting
  • Urothelial Carcinoma
  • Tremelimumab
  • Washington, District of Columbia
  • +6 more
Feb 24, 2022

Esophageal Adenocarcinoma Trial in Cologne, München (Durvalumab 50 MG/ML, Tremelimumab)

Recruiting
  • Esophageal Adenocarcinoma
  • Durvalumab 50 MG/ML
  • Tremelimumab
  • Cologne, Germany
  • +1 more
Feb 17, 2022

Mesothelioma, Malignant Trial in Toronto (Cyclophosphamide, Tremelimumab, Durvalumab)

Recruiting
  • Mesothelioma, Malignant
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 13, 2022

Advanced and/or Metastatic Sarcoma Trial in Houston (Durvalumab, Tremelimumab)

Active, not recruiting
  • Advanced and/or Metastatic Sarcoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 7, 2022

Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor Trial

Active, not recruiting
  • Fallopian Tube Endometrioid Tumor
  • +13 more
  • Orange, California
  • +19 more
Jan 10, 2023

Bladder Cancer Trial in Spain (Durvalumab, Tremelimumab, Cisplatin-based neoadjuvant chemo)

Active, not recruiting
  • Bladder Cancer
  • Badalona, Spain
  • +10 more
Feb 8, 2022

Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021

Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Dresden, Germany
  • +7 more
Apr 13, 2022

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Colorectal Cancer Metastatic Trial in United States (durvalumab, Tremelimumab)

Completed
Has Results
  • Colorectal Cancer Metastatic
  • Duarte, California
  • +17 more
Nov 8, 2022

Solid Malignancies Trial in Canada (durvalumab, tremelimumab)

Active, not recruiting
  • Solid Malignancies
  • Calgary, Alberta, Canada
  • +6 more
Jan 24, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma Trial in Edmonton, London, Montréal (SBRT, Durvalumab,

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Metastatic Squamous Cell Carcinoma
  • SBRT
  • +2 more
  • Edmonton, Alberta, Canada
  • +2 more
Mar 14, 2022

Prostate Cancer Trial in Canada (Durvalumab, Tremelimumab)

Active, not recruiting
  • Prostate Cancer
  • Kelowna, British Columbia, Canada
  • +10 more
Mar 14, 2022

Renal Clear Cell Carcinoma, Renal Papillary Cell Carcinoma Trial in London (Savolitinib, MEDI4736, Tremelimumab)

Active, not recruiting
  • Renal Clear Cell Carcinoma
  • Renal Papillary Cell Carcinoma
  • London, United Kingdom
    Thomas Powles
Aug 10, 2022

Metastatic Thyroid Papillary Carcinoma, Metastatic Thyroid Follicular Carcinoma, Metastatic Thyroid Cancer Trial in Spain

Recruiting
  • Metastatic Thyroid Papillary Carcinoma
  • +2 more
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +14 more
Feb 18, 2022

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (Durvalumab, Tremelimumab)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
  • +46 more
May 22, 2023

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Oct 26, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Head and Neck Squamous Cell Carcinoma, Lung Cancer, Oesophageal Cancer Trial in Villejuif (Durvalumab, Tremelimumab, SBRT)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy
Jul 21, 2021